Delivery Order SPE2DB20D2001-SPE2DB25FPMSW

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $78,705.00 and is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a firm fixed-price type with an ultimate completion date of April 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a ceiling value of $32,245.00. The contract is a firm fixed price delivery order with a completion date of May 20, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a ceiling value of $3,152.10 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,659.10, is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including prescription medications, medical devices, and specialized supplies. The contract has a ceiling value of $1,891.26 and a period of performance through May 1, 2025. It is a firm fixed-price contract for the delivery of 4568092758 MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,881.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is April 15, 2025. The contract does not have a set-aside designation, indicating open...
This is a $1,217.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML" with a completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a range of pharmaceutical products and medical...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,952.50 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which are likely vaccines or other medical products. The contract has a ceiling value of $57,926.88 and a period of performance through April 1, 2025. The contract is a firm fixed price type and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $44,074.80, is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract is a firm fixed-price delivery order with a period of performance through November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMSW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a ceiling value of $19,099.02 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside.

AmerisourceBergen Drug Corporation holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/18/25, 9:51 AM